L3VLUP
ProSign in

KOD · AMGN in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

KODAMGN
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • KOD
  • AMGN
0102030202120222023202420252026
Holders and value by quarter
QuarterKODAMGN
Q3 20202 holders, $473m16 holders, $16.3bn
Q4 20203 holders, $1.6bn19 holders, $14.0bn
Q1 20213 holders, $1.3bn16 holders, $14.5bn
Q2 20214 holders, $1.3bn23 holders, $13.8bn
Q3 20213 holders, $1.4bn24 holders, $11.6bn
Q4 20213 holders, $1.2bn21 holders, $10.4bn
Q1 20222 holders, $3.7m23 holders, $9.9bn
Q2 20223 holders, $7.0m28 holders, $9.7bn
Q3 20223 holders, $5.8m21 holders, $7.9bn
Q4 20223 holders, $6.3m24 holders, $9.3bn
Q1 20232 holders, $4.6m22 holders, $8.4bn
Q2 2023none listed holders, n.a.26 holders, $7.4bn
Q3 2023none listed holders, n.a.26 holders, $8.7bn
Q4 20231 holders, $5.8m24 holders, $8.4bn
Q1 20242 holders, $12m25 holders, $6.7bn
Q2 2024none listed holders, n.a.20 holders, $8.0bn
Q3 20241 holders, $5.1m21 holders, $8.8bn
Q4 20241 holders, $15m20 holders, $8.2bn
Q1 20251 holders, $5.5m25 holders, $12.0bn
Q2 20251 holders, $7.3m20 holders, $10.2bn
Q3 20253 holders, $63m17 holders, $10.4bn
Q4 20254 holders, $105m19 holders, $18.0bn
Q1 20263 holders, $78m15 holders, $21.4bn
Q2 20263 holders, $99m23 holders, $24.9bn
KOD

Kodiak Sciences Inc

Holders
3
Reported value
$63m
Buyers
2
Sellers
1

Breadth +1 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP
AMGN

Amgen Inc

Holders
17
Reported value
$10.4bn
Buyers
8
Sellers
9

Breadth -1 among 95 comparable managers.

Pharmaceuticals and biotechnologyBiological productsHealthcare: biopharma and medtech · L3VLUP

Who holds both, Q3 2025

Among the 19 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only KOD (2)

Point72 Asset Management LP, Polen Capital Management LLC

Only AMGN (16)

AllianceBernstein LP, ARK Investment Management LLC, Capital Research Global Investors, Capital World Investors, Dodge & Cox, ExodusPoint Capital Management LP, Fidelity (FMR LLC), Invesco Ltd, Janus Henderson Group Ltd, Man Group PLC, Renaissance Technologies LLC, T. Rowe Price Associates Inc, Tudor Investment Corp, Two Sigma Advisers LP, Verition Fund Management LLC, Woodline Partners LP

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →